Researchers from Queen Mary University London says aspirin reduces risk cancer

Aspirin reduces risk of cancer, finds new study

11:08 AM, 6th August 2014
Aspirin reduces risk of cancer, finds new study
According to a new study, taking a small daily dose of aspirin can significantly reduce the risk of developing - or dying from - bowel, stomach and oesophageal cancer.

LONDON, UK: According to a large review of scientific studies, taking a small daily dose of aspirin can significantly reduce the risk of developing - or dying from - bowel, stomach and oesophageal cancer. Researchers who analyzed all available evidence from studies and clinical trials assessing benefits and harm found that taking aspirin for 10 years could cut bowel cancer cases by around 35 per cent and deaths from the disease by 40 per cent. Rates of oesophageal and stomach cancer were cut by 30 per cent and deaths from these cancers by 35 to 50 per cent.

Professor Jack Cuzick, head of the centre for cancer prevention at Queen Mary University of London, said the evidence showed that, to reap the benefits of aspirin, people need to take a daily dose of 75 to 100 milligrams for at least five years and probably up to 10 years between the ages of 50 and 65. No benefit was seen while taking aspirin for the first three years and death rates were only reduced after five years, he and his team reported in a review in the Annals of Oncology journal.

“Our study shows that if everyone aged between 50 and 65 started taking aspirin daily for at least 10 years, there would be a 9 per cent reduction in the number of cancers, strokes and heart attacks overall in men, and around 7 per cent in women,” said Cuzick.

But the researchers also warned that taking aspirin long-term increases the risk of bleeding in the stomach: among 60-year-olds who take daily aspirin for 10 years, the risk of digestive tract bleeding increases from 2.2 per cent to 3.6 per cent, and this could be life-threatening in a small proportion of people, they said.

“Whilst there are some serious side effects that can’t be ignored, taking aspirin daily looks to be the most important thing we can do to reduce cancer after stopping smoking and reducing obesity, and will probably be much easier to implement,” said Cuzick.

Aspirin, originally developed by the German drugmaker Bayer, is a cheap, over-the-counter drug generally used to combat pain or reduce fever. The drug reduces the risk of clots forming in blood vessels and can therefore protect against heart attacks and strokes, so it is often prescribed for people who already suffer with heart disease and have already had one or several attacks.

Aspirin also increases the risk of bleeding in the stomach to around one patient in every thousand per year, a factor which has fuelled debate over whether doctors should advise patients to take it as regularly as every day.

According to Cuzick, the risk of bleeding ‘depends on a number of known factors which people need to be aware of before starting regular aspirin’ and advised people to consult a doctor before embarking on daily medication.

 

© TimesOfIndia News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Shell starts oil production in Nigeria

ABUJA, NIGERIA: Shell Nigeria Exploration and Production Company Ltd (SNEPCo), Shell’s deep-water subsidiary in Nigeria, started oil production ...

Read more
Mexichem to acquire PVC producer, VESTOLIT

TLALNEPANTLA, ESTADO DE MEXICO: Mexichem, has signed a definitive agreement to acquire VESTOLIT GmbHH, the 6th largest producer of polyvinyl chloride ...

Read more
Hiroshima nuclear attack hits 69th anniversary

HIROSHIMA, JAPAN: Today, 6 August 2014, marks the 69th anniversary of nuclear attack on Hiroshima. An American B-29 bomber named Enola Gay dropped an ...

Read more
RusVinyl starts trial batch production of polyvinyl chloride

KSTOVO, RUSSIA: RusVinyl has started up scheduled trial batch of polyvinyl chloride (PVC). Several days earlier RusVinyl obtained the trial batch of c ...

Read more
Yara to acquire 60 pc stake in fertilizer company, Galvani

OSLO, NORWAY: Yara International ASA has entered into an agreement to acquire a 60 per cent stake in Galvani Industria, Comercio e Serviços S/A ...

Read more
Ashland sells water technologies business for $1.8 billion

COVINGTON, US: Ashland Inc has completed the previously announced sale of Ashland Water Technologies to a fund managed by Clayton, Dubilier & Rice ...

Read more